Oh-Biologika-2023-29 - Tocilizumab

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 72759464

  Document Type - Tender Notices

Description - The participating health insurance companies pursue the goal of concluding discount agreements with all suitable pharmaceutical companies in accordance with Section 130a Paragraph 8 SGB V for the active ingredient tocilizumab. The contract is conclud ed as part of the open house biologics procedure of the participating health insurance companies: Individual negotiations regarding contract contents are not conducted; uniform conditions apply. The health insurance companies involved do not guarantee individual contractual partners any exclusivity. The contract term is a maximum of 24 months starting on November 1st, 2023. The contract ends on October 31, 2025 at the latest, regardless of the da

Gt Ref Id - 72759464

Deadline - Oct 31, 2025